(E)-6-(2',6'-dichlorostyryl)-4-methoxy-5-(methoxymethyl)-2H-pyran-2-one

ID: ALA1099213

PubChem CID: 46861772

Max Phase: Preclinical

Molecular Formula: C16H14Cl2O4

Molecular Weight: 341.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCc1c(OC)cc(=O)oc1/C=C/c1c(Cl)cccc1Cl

Standard InChI:  InChI=1S/C16H14Cl2O4/c1-20-9-11-14(22-16(19)8-15(11)21-2)7-6-10-12(17)4-3-5-13(10)18/h3-8H,9H2,1-2H3/b7-6+

Standard InChI Key:  OJAQHGSUGFPQST-VOTSOKGWSA-N

Molfile:  

     RDKit          2D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.1390    1.4757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1404    0.6481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5726    0.2354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2918    0.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2886    1.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5707    1.8884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0009    1.8957    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5712   -0.5895    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.0066    0.2369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7205    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4353    0.2383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4312   -0.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1419   -0.9992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8583   -0.5896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8596    0.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1443    0.6524    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7156   -0.9977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7130   -1.8225    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9972   -2.2328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1395   -1.8241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4240   -2.2346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5750    0.6468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
 11 12  2  0
  5  6  2  0
  6  1  1  0
  1  2  2  0
  5  7  1  0
  3  4  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
  3  8  1  0
 12 17  1  0
 17 18  1  0
  4  9  1  0
 18 19  1  0
  4  5  1  0
 13 20  1  0
  9 10  2  0
 20 21  1  0
  2  3  1  0
 15 22  2  0
M  END

Associated Targets(non-human)

Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 Mitogen-activated protein kinase 1 and 3 (ERK2 and ERK1) (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akt1 RAC-alpha serine/threonine-protein kinase (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.19Molecular Weight (Monoisotopic): 340.0269AlogP: 4.27#Rotatable Bonds: 5
Polar Surface Area: 48.67Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.45CX LogD: 3.45
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: -0.02

References

1. Tanaka A, Hamada N, Fujita Y, Itoh T, Nozawa Y, Iinuma M, Ito M..  (2010)  A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2/ARE activation.,  18  (9): [PMID:20371185] [10.1016/j.bmc.2010.03.034]

Source